Michael R. Gold

Overview

Best Publications

• Subclinical Atrial Fibrillation and the Risk of Stroke

  Jeff S. Healey;Stuart J. Connolly;Michael R. Gold;Carsten W. Israel

  2271
  Citations

• Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

  Cecilia Linde;William T. Abraham;Michael R. Gold;Martin St. John Sutton

  1682
  Citations

• Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

  Wojciech Zareba;Helmut Klein;Iwona Cygankiewicz;W. Jackson Hall

  940
  Citations

• 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

  Fred M. Kusumoto;Mark H. Schoenfeld;Coletta Barrett;James R. Edgerton

  904
  Citations

• Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

  Michela Brambatti;Stuart J. Connolly;Michael R. Gold;Carlos A. Morillo

  738
  Citations

• Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death

  A E Buxton;K L Lee;L DiCarlo;M R Gold

  686
  Citations

• An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

  John G. Cleland;William T. Abraham;Cecilia Linde;Michael R. Gold

  595
  Citations

• Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

  Raul Weiss;Bradley P. Knight;Michael R. Gold;Angel R. Leon

  558
  Citations

• Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchronization Therapy

  Kenneth A. Ellenbogen;Michael R. Gold;Timothy E. Meyer;Ignacio Fernández Lozano

  545
  Citations

• Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

  Isabelle C. Van Gelder;Jeff S. Healey;Harry J. G. M. Crijns;Jia Wang

  536
  Citations

• Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry

  Martin C. Burke;Michael R. Gold;Bradley P. Knight;Craig S. Barr

  527
  Citations

• Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study

  Alfred E. Buxton;Kerry L. Lee;Gail E. Hafley;Luis A. Pires

  491
  Citations

• Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

  Claude Daubert;Michael R. Gold;William T. Abraham;Stefano Ghio

  482
  Citations

• Electrical Storm Presages Nonsudden Death The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial

  Derek V. Exner;Sergio L. Pinski;D. George Wyse;Ellen Graham Renfroe

  459
  Citations

• The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS)

  George H. Crossley;Jeanne E. Poole;Marc A. Rozner;Samuel J. Asirvatham

  408
  Citations

• Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

  Michael R. Gold;Christophe Thébault;Cecilia Linde;William T. Abraham

  378
  Citations

• The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy

  Michael R. Gold;Ulrika Birgersdotter-Green;Jagmeet P. Singh;Kenneth A. Ellenbogen

  368
  Citations

• A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification

  Michael R Gold;Daniel M Bloomfield;Kelley P Anderson;Nabil E El-Sherif

  359
  Citations

• Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study.

  Michael R. Gold;Zenaida Feliciano;Stephen S. Gottlieb;Michael L. Fisher

  351
  Citations

• 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay

  Fred M. Kusumoto;Mark H. Schoenfeld;Coletta Barrett;James R. Edgerton

  122
  Citations